Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
29/05/2018 1:28 pm
Bloodwork question about liraglutide. Baseline, four months in, and the numbers moved in a direction I did not expect.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Muscle loss is the thing to watch, which means protein and resistance training rather than appetite alone.
The interesting question is not whether it works but for whom and at what cost.